Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer

Clinical trial NCT01896856 · COMPLETED

Trial details

NCT number

NCT01896856

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Status

COMPLETED

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2013-10-23

Primary completion

2019-08-26

Enrollment

118

View on ClinicalTrials.gov